Pharma can leverage value-based care/contracts (VBCs) to differentiate and demonstrate the effectiveness of their beyond-the-pill initiatives versus their competitors, which can assist payers in making formulary and other reimbursement decisions. Payers can use VBCs to gain experience with a beyond-the-pill solution or program, reducing uncertainty regarding clinical value, performance and financial impact.


This webinar highlights the opportunities and risks of VBC for innovation-driven pharmaceutical organizations that are either wading or diving head first into the digital health space.